Can target-to-pons ratio be used as a reliable method for the analysis of [ 11C]PIB brain scans?

NeuroImage

Volumn 60, Issue 3, 2012, Pages 1716-1723

  Edison, P ^a   Hinz, R ^b   Ramlackhansingh, A ^a   Thomas, J ^a   Gelosa, G ^a   Archer, H A ^c   Turkheimer, F E ^a   Brooks, D J ^a,d  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d GE HEALTHCARE   (United Kingdom)

Author keywords

Alzheimer; Amyloid; Genetic; PIB; Pons; Presenilin

Indexed keywords

PITTSBURGH COMPOUND B; PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; BRAIN CORTEX; BRAIN SCINTISCANNING; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SCREENING TEST; SYMPTOMATOLOGY; TARGET TO PONS RATIO; TEST RETEST RELIABILITY;

ALZHEIMER DISEASE; BENZOTHIAZOLES; CEREBELLUM; FEMALE; FIDUCIAL MARKERS; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PONS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84863418985     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.01.099     Document Type: Article

References (31)

1. Aalto S., Scheinin N.M., Kemppainen N.M., Nagren K., Kailajarvi M., Leinonen M., Scheinin M., Rinne J.O. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:1651-1660.
2. American Psychiatric Association, 1994. Diagnostic and statistical manual of mental disorders, Fourth edition, Text revision.
3. Drzezga A., Grimmer T., Henriksen G., Stangier I., Perneczky R., Diehl-Schmid J., Mathis C.A., Klunk W.E., Price J., Dekosky S., Wester H.J., Schwaiger M., Kurz A. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease 2007, Neuroimage.
4. Edison P., Archer H.A., Hinz R., Hammers A., Pavese N., Tai Y.F., Hotton G., Cutler D., Fox N., Kennedy A., Rossor M., Brooks D.J. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 2007, 68:501-508.
5. Edison P., Rowe C.C., Rinne J.O., Ng S., Ahmed I., Kemppainen N., Villemagne V.L., O'Keefe G., Nagren K., Chaudhuri R., Masters C.L., Brooks D.J. Amyloid load in Parkinson's disease dementia and Lewy Body dementia measured with [11C]PIB-PET 2008, J Neurol Neurosurg Psychiatry.
6. Edison P., Brooks D.J., Turkheimer F.E., Archer H.A., Hinz R. Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility. NeuroImage 2009, 48:329-338.
7. Engler H., Forsberg A., Almkvist O., Blomquist G., Larsson E., Savitcheva I., Wall A., Ringheim A., Langstrom B., Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 2006, 129:2856-2866.
8. Forsberg A., Engler H., Almkvist O., Blomquist G., Hagman G., Wall A., Ringheim A., Langstrom B., Nordberg A. PET imaging of amyloid deposition in patients with mild cognitive impairment 2007, Neurobiol Aging.
9. Ghiso J., Frangione B. Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia. J. Alzheimers Dis. 2001, 3:65-73.
10. Gomperts S.N., Rentz D.M., Moran E., Becker J.A., Locascio J.J., Klunk W.E., Mathis C.A., Elmaleh D.R., Shoup T., Fischman A.J., Hyman B.T., Growdon J.H., Johnson K.A. Imaging amyloid deposition in Lewy body diseases. Neurology 2008, 71:903-910.
11. Gunn R.N., Lammertsma A.A., Hume S.P., Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 1997, 6:279-287.
12. Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., Duncan J.S. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 2003, 19:224-247.
13. Hinz R., Turkheimer F.E. Determination of tracer arrival delay with spectral analysis. IEEE Trans. Nucl. Sci. 2006, 53:212-219.
14. Kaufer I.D., Yuen H., DeKosky S., Klunk W. Cerebellar amyloid in a case of early-onset dementia with a presenilin-1 mutation: correlation to clinical phenotype. Alzheimer's Dementia 2008, 4:T290-T291.
15. Kemppainen N.M., Aalto S., Wilson I.A., Nagren K., Helin S., Bruck A., Oikonen V., Kailajarvi M., Scheinin M., Viitanen M., Parkkola R., Rinne J.O. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 2007, 68:1603-1606.
16. Klunk W.E., Wang Y., Huang G.F., Debnath M.L., Holt D.P., Mathis C.A. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 2001, 69:1471-1484.
17. Klunk W.E., Wang Y., Huang G.F., Debnath M.L., Holt D.P., Shao L., Hamilton R.L., Ikonomovic M.D., DeKosky S.T., Mathis C.A. The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J. Neurosci. 2003, 23:2086-2092.
18. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
19. Klunk W.E., Price J.C., Mathis C.A., Tsopelas N.D., Lopresti B.J., Ziolko S.K., Bi W., Hoge J.A., Cohen A.D., Ikonomovic M.D., Saxton J.A., Snitz B.E., Pollen D.A., Moonis M., Lippa C.F., Swearer J.M., Johnson K.A., Rentz D.M., Fischman A.J., Aizenstein H.J., DeKosky S.T. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J. Neurosci. 2007, 27:6174-6184.
20. Lockhart A., Lamb J.R., Osredkar T., Sue L.I., Joyce J.N., Ye L., Libri V., Leppert D., Beach T.G. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain 2007, 130:2607-2615.
21. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl. Med. Biol. 2000, 27:661-670.
22. Lopresti B.J., Klunk W.E., Mathis C.A., Hoge J.A., Ziolko S.K., Lu X., Meltzer C.C., Schimmel K., Tsopelas N.D., Dekosky S.T., Price J.C. Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis. J. Nucl. Med. 2005, 46:1959-1972.
23. Mathis C.A., Bacskai B.J., Kajdasz S.T., McLellan M.E., Frosch M.P., Hyman B.T., Holt D.P., Wang Y., Huang G.F., Debnath M.L., Klunk W.E. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg. Med. Chem. Lett. 2002, 12:295-298.
24. Mathis C.A., Wang Y., Holt D.P., Huang G.F., Debnath M.L., Klunk W.E. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem. 2003, 46:2740-2754.
25. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
26. Mead S., Poulter M., Beck J., Webb T.E., Campbell T.A., Linehan J.M., Desbruslais M., Joiner S., Wadsworth J.D., King A., Lantos P., Collinge J. Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 2006, 129:2297-2317.
27. Price J.C., Klunk W.E., Lopresti B.J., Lu X., Hoge J.A., Ziolko S.K., Holt D.P., Meltzer C.C., DeKosky S.T., Mathis C.A. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J. Cereb. Blood Flow Metab. 2005, 25:1528-1547.
28. Rabinovici G.D., Furst A.J., O'Neil J.P., Racine C.A., Mormino E.C., Baker S.L., Chetty S., Patel P., Pagliaro T.A., Klunk W.E., Mathis C.A., Rosen H.J., Miller B.L., Jagust W.J. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007, 68:1205-1212.
29. Ranicar A.S., Williams C.W., Schnorr L., Clark J.C., Rhodes C.G., Bloomfield P.M., Jones T. The on-line monitoring of continuously withdrawn arterial blood during PET studies using a single BGO/photomultiplier assembly and non-stick tubing. Med. Prog. Technol. 1991, 17:259-264.
30. Watanabe R., Duchen L.W. Cerebral amyloid in human prion disease. Neuropathol. Appl. Neurobiol. 1993, 19:253-260.
31. Yaqub M., Tolboom N., Boellaard R., van Berckel B.N., van Tilburg E.W., Luurtsema G., Scheltens P., Lammertsma A.A. Simplified parametric methods for [(11)C]PIB studies. NeuroImage 2008, 42:76-86.